IL48557A - Polyhalo hydroxy isopropyl substituted aryl ureas,oxazolinines or quinazolines,process for their preparation and pharmaceutical compositions containing them - Google Patents

Polyhalo hydroxy isopropyl substituted aryl ureas,oxazolinines or quinazolines,process for their preparation and pharmaceutical compositions containing them

Info

Publication number
IL48557A
IL48557A IL48557A IL4855775A IL48557A IL 48557 A IL48557 A IL 48557A IL 48557 A IL48557 A IL 48557A IL 4855775 A IL4855775 A IL 4855775A IL 48557 A IL48557 A IL 48557A
Authority
IL
Israel
Prior art keywords
oxazolinines
polyhalo
quinazolines
preparation
pharmaceutical compositions
Prior art date
Application number
IL48557A
Other languages
English (en)
Other versions
IL48557A0 (en
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of IL48557A0 publication Critical patent/IL48557A0/xx
Publication of IL48557A publication Critical patent/IL48557A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL48557A 1974-12-02 1975-11-27 Polyhalo hydroxy isopropyl substituted aryl ureas,oxazolinines or quinazolines,process for their preparation and pharmaceutical compositions containing them IL48557A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52860374A 1974-12-02 1974-12-02

Publications (2)

Publication Number Publication Date
IL48557A0 IL48557A0 (en) 1976-01-30
IL48557A true IL48557A (en) 1979-05-31

Family

ID=24106378

Family Applications (1)

Application Number Title Priority Date Filing Date
IL48557A IL48557A (en) 1974-12-02 1975-11-27 Polyhalo hydroxy isopropyl substituted aryl ureas,oxazolinines or quinazolines,process for their preparation and pharmaceutical compositions containing them

Country Status (26)

Country Link
JP (1) JPS5182239A (fr)
AR (2) AR219478A1 (fr)
AT (1) AT357557B (fr)
AU (1) AU501512B2 (fr)
BE (1) BE835899A (fr)
CA (1) CA1063112A (fr)
CH (1) CH623044A5 (fr)
CS (1) CS188259B2 (fr)
DD (1) DD124730A5 (fr)
DE (1) DE2552933A1 (fr)
DK (1) DK535275A (fr)
FI (1) FI753332A (fr)
FR (1) FR2346000A1 (fr)
GB (1) GB1507340A (fr)
HU (1) HU175541B (fr)
IE (1) IE42759B1 (fr)
IL (1) IL48557A (fr)
IT (1) IT1051024B (fr)
LU (1) LU73888A1 (fr)
NL (1) NL7513804A (fr)
NO (1) NO146497C (fr)
PH (1) PH14474A (fr)
PL (2) PL99122B1 (fr)
SE (2) SE7513331L (fr)
SU (2) SU655311A3 (fr)
ZA (1) ZA757457B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52111541A (en) * 1976-02-19 1977-09-19 Scherico Ltd Substituted ureido compound and medical composition containing it as active ingredient
US4107303A (en) 1976-06-24 1978-08-15 E. I. Du Pont De Nemours And Company Antihypertensive hexafluorohydroxyisopropyl benzazepines and benzazocines
DE2839462A1 (de) * 1978-09-11 1980-03-27 Basf Ag Aroylharnstoffe
US6316503B1 (en) * 1999-03-15 2001-11-13 Tularik Inc. LXR modulators
EP1476425A4 (fr) 2002-01-30 2010-05-05 Amgen Inc Composes arylsulfonamidobenzyliques heterocycliques
ES2314212T3 (es) 2002-01-30 2009-03-16 Amgen Inc. Compuestos arilsulfonamidobencilicos.
US20030199578A1 (en) * 2002-04-19 2003-10-23 Turner Sean C. Naphthalene amides as potassium channel openers
KR20170076673A (ko) * 2014-10-24 2017-07-04 오노 야꾸힝 고교 가부시키가이샤 Kcnq2∼5 채널 활성화제
JP6197971B1 (ja) * 2016-04-22 2017-09-20 小野薬品工業株式会社 Kcnq2〜5チャネル関連疾患の予防および/または治療剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453284A (en) * 1966-01-19 1969-07-01 Du Pont Certain 2-(substituted-anilino)-2-oxazolines
FR1543535A (fr) * 1966-09-27 1968-10-25 Bayer Ag Procédé de fabrication de 2-phénylamino-2-oxazolines
FR1543534A (fr) * 1966-09-27 1968-10-25 Bayer Ag Procédé de fabrication de 2-phénylimino-oxazolidines
DE1670751A1 (de) * 1966-09-27 1970-12-23 Bayer Ag Verfahren zur Herstellung von 2-Phenylamino-2-oxazolinen
DE1670752A1 (de) * 1966-09-27 1970-12-23 Bayer Ag Verfahren zur Herstellung von 2-Phenylamino-oxazolinen

Also Published As

Publication number Publication date
CA1063112A (fr) 1979-09-25
CH623044A5 (en) 1981-05-15
NO146497C (no) 1982-10-13
NO753984L (fr) 1976-06-03
DD124730A5 (fr) 1977-03-09
NL7513804A (nl) 1976-06-04
SE8004364L (sv) 1980-06-11
PH14474A (en) 1981-08-07
FI753332A (fr) 1976-06-03
SU685146A3 (ru) 1979-09-05
AU8698975A (en) 1977-06-02
ATA898575A (de) 1979-12-15
PL99122B1 (pl) 1978-06-30
JPS5182239A (fr) 1976-07-19
SE7513331L (sv) 1976-06-03
AU501512B2 (en) 1979-06-21
BE835899A (fr) 1976-05-25
DE2552933A1 (de) 1976-06-10
DK535275A (da) 1976-06-03
AR219478A1 (es) 1980-08-29
IE42759B1 (en) 1980-10-08
HU175541B (hu) 1980-08-28
IT1051024B (it) 1981-04-21
CS188259B2 (en) 1979-02-28
ZA757457B (en) 1976-11-24
FR2346000A1 (fr) 1977-10-28
LU73888A1 (fr) 1976-09-06
GB1507340A (en) 1978-04-12
IE42759L (en) 1976-06-02
IL48557A0 (en) 1976-01-30
FR2346000B1 (fr) 1978-11-17
PL102327B1 (pl) 1979-03-31
SU655311A3 (ru) 1979-03-30
AR218436A1 (es) 1980-06-13
AT357557B (de) 1980-07-25
NO146497B (no) 1982-07-05

Similar Documents

Publication Publication Date Title
IL48642A (en) 3-amino-indazolecarboxylic acid derivatives,ther preparation and pharmaceutical compositions containing them
IL46760A (en) 2-tetrahydrofurfuryl-6,7-benzomorphane derivatives,their production and pharmaceutical compositions containing them
IL47095A0 (en) Thienyl and thietyl ureas,their preparation and pharmaceutical compositions containing them
IL47360A (en) -amino- and -formyl- -(p-acycloxyphenyl) acetamido-3-cephem-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL47877A0 (en) Novel thienothiazine derivatives,their manufacture and pharmaceutical compositions containing them
IL48557A (en) Polyhalo hydroxy isopropyl substituted aryl ureas,oxazolinines or quinazolines,process for their preparation and pharmaceutical compositions containing them
IL47735A (en) 8a-substituted-6-alkyl-ergoline i derivatives,their production and pharmaceutical compositions containing them
IL47404A0 (en) Pyrazolobenzazepines,their manufacture and pharmaceutical compositions containing them
IL47149A0 (en) New amino acid derivatives,their preparation and pharmaceutical compositions containing them
IL48697A0 (en) Novel xanthine derivatives,their preparation and pharmaceutical compositions containing them
IL47299A (en) 3-thiomethyl-3-cephem-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL48054A0 (en) New vincanol derivatives,their production and pharmaceutical compositions containing them
IL46593A0 (en) New 2-amino-6-dialkylaminodihydropyridines,their production and pharmaceutical compositions containing them
IL47519A (en) 7-sulphinimidoyl(sulphimidoyl)-xanthone-2-carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
IL48183A0 (en) New cephalosporin derivatives,processes for their preparation and pharmaceutical compositions containing them
IL46957A0 (en) Novel theophylline derivatives,their preparation and pharmaceutical compositions containing them
IL48526A0 (en) Diaryloxy-imidazolyl-o,n-acetals,their preparation and pharmaceutical compositions containing them
IL45865A0 (en) 4-oxo-2-imidazolidinylidene ureas,their preparation and pharmaceutical compositions containing them
IL46914A0 (en) Pyridylalkylamidines,processes for their preparation and pharmaceutical compositions containing them
IL47097A (en) Cyclohexenyl ureas,their preparation and pharmaceutical compositions containing them
IL46890A0 (en) New-1-aryl-uracils,their production and pharmaceutical compositions containing them
IL46194A0 (en) Dibenzoxepin compounds,their preparation and pharmaceutical compositions containing them
IL47085A0 (en) Ergoline compounds,their production and pharmaceutical compositions containing them
IL48239A0 (en) Novel d-homosteroids,their manufacture and pharmaceutical compositions containing them
IL48208A (en) L -fluoro-21-hydroxy-16 -methyl- 1,4,8-pregnatriene derivatives,process for their preparation and pharmaceutical compositions containing them